Results 1-2 of 2 (Search time: 0.002 seconds).
Start Date | Title | P-Investigator | Funding Organization/經費來源 |
---|---|---|---|
2019 | Phase I Trial Allocation Directed by Immunologically Classified Cancers Refractory to Anti-Pd-1 / Pd-L1 Antibodies | CHIA-CHI LIN | National Science and Technology Council |
2019 | Taiwan Clinical Trial Consortium for Oncology Phase I Trials | CHIA-CHI LIN | National Science and Technology Council |